SIGMA DIAGNOSTICS CALICIUM REAGENT

K963536 · Sigma Diagnostics, Inc. · CJY · Oct 10, 1996 · Clinical Chemistry

Device Facts

Record IDK963536
Device NameSIGMA DIAGNOSTICS CALICIUM REAGENT
ApplicantSigma Diagnostics, Inc.
Product CodeCJY · Clinical Chemistry
Decision DateOct 10, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1145
Device ClassClass 2

Intended Use

The Sigma Diagnostics Calcium Reagent, Procedure Number C7183, is intended for the quantitative determination of calcium in serum, plasma, or urine on the SYNCHRON CX®3 System.

Device Story

In vitro diagnostic reagent for quantitative calcium measurement; utilizes arsenazo III method; designed for use on SYNCHRON CX®3 System. Input: serum, plasma, or urine samples. Process: chemical reaction with reagent; sample blanking on analyzer to enhance specificity; eliminates magnesium interference. Output: calcium concentration values. Used in clinical laboratories by technicians/pathologists. Results assist clinicians in diagnosing calcium-related metabolic disorders and monitoring bone/kidney function.

Clinical Evidence

Bench testing only. Comparison study against predicate using serum and urine samples. Serum: correlation coefficient 0.982, regression y=0.95x+0.54. Urine: correlation coefficient 0.996, regression y=1.02x-0.15. Precision: within-run and total precision %CV < 2.4% (serum) and < 1.5% (urine). Linearity established up to 15.5 mg/dL.

Technological Characteristics

Arsenazo III colorimetric reagent; single-reagent system. Designed for automated analysis on SYNCHRON CX®3 System. Features sample blanking to minimize magnesium interference. Linear range up to 15.5 mg/dL.

Indications for Use

Indicated for the quantitative measurement of calcium in serum, plasma, or urine to assist in the diagnosis and monitoring of diseases associated with hypercalcemia (e.g., primary hyperthyroidism, malignancy) and hypocalcemia (e.g., hypoparathyroidism, vitamin D deficiency, rickets, intestinal malabsorption).

Regulatory Classification

Identification

A calcium test system is a device intended to measure the total calcium level in serum. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} K963536 510(k) NOTIFICATION Sigma Diagnostics 545 South Ewing Avenue St. Louis, MO 63103 CX®-3 Calcium Reagent Procedure No. C7183 August 30, 1996 OCT 10 1996 # ATTACHMENT 1 ## Summary of Safety and Effectiveness {1} K963536 510(K) NOTIFICATION Sigma Diagnostics 545 South Ewing Avenue St. Louis, MO 63103 CX®3 Calcium Reagent Procedure Number C7183 August 31, 1996 # SUMMARY OF SAFETY AND EFFECTIVENESS The concentration of calcium is determined by the balance between absorption in the intestine and excretion in the kidneys and by exchanges between plasma, extracellular fluid and tissues including bone. Diseases associated with hypercalcemia include primary hyperthyroidism and hypercalcemia of malignancy. Hypocalcemia is associated with hypoparathyroidism and pseudohypoparathyroidism, vitamin D deficiency, hereditary vitamin D dependency, rickets types I and II, and intestinal malabsorption.¹ Many methods exist for determining calcium. The o-cresophthalein complexone method remains popular in the clinical laboratory because performing it is fast and easy. The arsenazoIII method is a relatively new single reagent method. It is rapidly gaining popularity because it is even easier to use and has virtually no magnesium interference even at levels as high as 20 mg/dL.² Further modifications to the method, in conjunction with sample blanking on the SYNCHRON CX®3 System, have resulted in a rapid calcium test with increased specificity. The safety and effectiveness of Sigma Diagnostics Calcium Reagent, Procedure Number C7183, are demonstrated by its substantial equivalency to Beckman Calcium Reagent Kit, Part No. 450890. Both calcium reagents are used to measure calcium concentrations in serum, plasma, or urine on the SYNCHRON CX®3 System, and the reaction principles for both are identical. In comparison studies, a correlation coefficient of 0.982 and a regression equation of y = 0.95x + 0.54 was obtained with serum samples; and a correlation coefficient of 0.996 and a regression equation of y = 1.02x - 0.15 was obtained with urine samples. With-in run precision and total precision demonstrated %CV’s of less than 2.4 % on serum samples and less than 1.5 % on urine samples. The Sigma Diagnostics Calcium Reagent has been determined to be linear to 15.5 mg/dL on the SYNCHRON CX®3 System. # REFERENCES 1. Textbook of Clinical Chemistry, N Tietz, Editor, WB Saunders, Co, Philadelphia, PA, 1986 2. Schmitz J, et al: Clin Chem 32: 1198, 1986
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...